Acute Pulmonary Embolism and Paradoxical Embolism in Patients with Patent Foramen Ovale: to Close or Not to Close…That is the Question!

Marco Zuin, Gianluca Rigatelli

Abstract


Nowadays, the treatment of patent foramen ovale (PFO) after acute pulmonary embolism (PE) remains matter of speculation. Absence of both randomized trials and recommendations in current international guidelines complicate the decisions making in such patients. In the present manuscript we discuss about the reasons for which PFO should be closed after acute PE.


Keywords


Patent Foramen Ovale; Pulmonary Embolism; Endovascular treatment

Full Text:

394

References


Hara H, Virmani R, Ladich E, et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 2005; 46:1768 DOI: 10.1016/j.jacc.2005.08.038;

Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options, Heart J 1986, 112:141-145;

Turfan M, Vatankulu MA, Murat SN, Oksuz F, Duran M, Ornek E. Thrombolytic treatment of simultaneous pulmonary embolism and impending paradoxical embolism through a patent foramen ovale: a different thrombolytic regimen. Heart Lung Circ. 2012;21:225-8 DOI: 10.1016/j.hlc.2011.10.001;

Thomas DV, Bynevelt M, Price R: Paradoxical embolization via a patent foramen ovale following acute pulmonary embolism. Australas Radiol 2005, 49:501-204 DOI: 10.1111/j.1440-1673.2005.01480.x;

Konstantinides S, Geibel A, Kasper W, Olschewski M, Blümel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97:1946-51;

Rigatelli G, Dell'Avvocata F, Vassiliev D, et al. Pathophysiology of paradoxical embolism: evaluation of the role of interatrial septum anatomy based on the intracardiac echocardiography assessment of patients with right-to-left shunting. Cardiol Young. 2015;25:47-55 DOI: 10.1017/S1047951113001480;

Kessel-Schaefer A, Lefkovits M, Zellweger MJ, Brett W, Rüter F, Pfisterer ME, Buser P. Migrating thrombus trapped in a patent foramen ovale. Circulation. 2001;103:1928;

Doyen D, Castellani M, Moceri P, et al. Patent foramen ovale and stroke in intermediate-risk pulmonary embolism. Chest. 2014;146:967-73 DOI: 10.1378/chest.14-0100;

Clergeau MR, Hamon M, Morello R, Saloux E, Viader F, Hamon M. Silent cerebral infarcts in patients with pulmonary embolism and a patent foramen ovale: a prospective diffusion-weighted MRI study. Stroke. 2009;40:3758-62 DOI: 10.1161/STROKEAHA.109.559898];

Wöhrle J. Closure of patent foramen ovale after cryptogenic stroke. Lancet. 2006;368:350-2 DOI: 10.1016/S0140-6736(06)69087-9];

Tanislav C, Puille M, Pabst W, Reichenberger F, Grebe M, Nedelmann M, Kaps M, Allendörfer J. High frequency of silent pulmonary embolism in patients with cryptogenic stroke and patent foramen ovale. Stroke. 2011; 42:822-4 DOI: 10.1161/STROKEAHA.110.601575;

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4.




DOI: https://doi.org/10.17987/icfj.v11i0.394

Comments on this article

View all comments


Copyright (c) 2017 The Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.